Keyphrases
Acute Myeloid Leukemia
100%
Event-free Survival
100%
Complete Remission
85%
Induction Failure
71%
Hematopoietic Cell Transplantation
42%
Survival Estimation
28%
Single-arm Trial
28%
Clinical Trials
14%
Cytarabine
14%
Newly Diagnosed
14%
Minimal Impact
14%
Induction Chemotherapy
14%
Oncology
14%
Anthracyclines
14%
Leukemia Patients
14%
Historical Controls
14%
Magnitude Difference
14%
Incorrect Conclusions
14%
Historical Control Data
14%
Medicine and Dentistry
Acute Myeloid Leukemia
100%
Event Free Survival
100%
Cell Transplantation
42%
Hematopoietic Cell
42%
Arm
28%
Survival Estimate
28%
Clinical Trial
14%
Cytarabine
14%
Oncology
14%
Induction Chemotherapy
14%
Anthracycline
14%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Myeloid Leukemia
100%
Event Free Survival
100%
Remission
85%
Clinical Trial
14%
Cytarabine
14%
Chemotherapy
14%
Anthracycline
14%
Immunology and Microbiology
Myeloid
100%
Event Free Survival
100%
Hematopoietic Cell
42%
Cell Transplantation
42%
Arm
28%
Engineering
Endpoint
100%
Hematopoietic Stem Cell
75%
Randomization
50%
Historical Control
50%
Veterinary Science and Veterinary Medicine
Myeloid
100%
Hematopoietic Cell
100%